March 11, 2020
“Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $2.2 million of its common stock… The combined purchase price for one share of common stock and each… Continue Reading…
Recent Comments